Randomised placebo controlled trials in HIV infection: to be or not to be?

Por Gelmon, K, Weller, I V
Publicado em 1989

Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art

Por Clemons, M., Gelmon, K.A., Pritchard, K.I., Paterson, A.H.G.
Publicado em 2012

Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience

Por Baxter, E., Gondara, L., Lohrisch, C., Chia, S., Gelmon, K., Hayes, M., Davidson, A., Tyldesley, S.
Publicado no Curr Oncol (2015)

Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor t...

Por Pritchard, K.I., Gelmon, K.A., Rayson, D., Provencher, L., Webster, M., McLeod, D., Verma, S.
Publicado em 2013

Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab

Por Seal, M.D., Speers, C.H., O’Reilly, S., Gelmon, K.A., Ellard, S.L., Chia, S.K.
Publicado em 2012

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer

Por Bebb, D G, Yu, Z, Chen, J, Telatar, M, Gelmon, K, Phillips, N, Gatti, R A, Glickman, B W
Publicado em 1999

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

Por Kalra, J, Sutherland, B W, Stratford, A L, Dragowska, W, Gelmon, K A, Dedhar, S, Dunn, S E, Bally, M B
Publicado em 2010

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial

Por Bartlett, J M S, Nielsen, T O, Gao, D, Gelmon, K A, Quintayo, M A, Starczynski, J, Han, L, Burnell, M J, Levine, M N, Chen, B E, Shepherd, L E, Chapman, J W
Publicado no Br J Cancer (2015)

Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy

Por Courneya, K S, McKenzie, D C, Mackey, J R, Gelmon, K, Friedenreich, C M, Yasui, Y, Reid, R D, Vallerand, J R, Adams, S C, Proulx, C, Dolan, L B, Wooding, E, Segal, R J
Publicado no Br J Cancer (2014)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

Por Goss, P.E., Ingle, J.N., Pritchard, K.I., Robert, N.J., Muss, H., Gralow, J., Gelmon, K., Whelan, T., Strasser-Weippl, K., Rubin, S., Sturtz, K., Wolff, A.C., Winer, E., Hudis, C., Stopeck, A., Beck, J.T., Kaur, J.S., Whelan, K., Tu, D., Parulekar, W.R.
Publicado no N Engl J Med (2016)

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

Por Yerushalmi, R., Dong, B., Chapman, J. W., Goss, P. E., Pollak, M. N., Burnell, M. J., Levine, M. N., Bramwell, V. H. C., Pritchard, K. I., Whelan, T. J., Ingle, J. N., Shepherd, L. E., Parulekar, W. R., Han, L., Ding, K., Gelmon, K. A.
Publicado no Ann Oncol (2017)

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

Por Wishart, G C, Bajdik, C D, Dicks, E, Provenzano, E, Schmidt, M K, Sherman, M, Greenberg, D C, Green, A R, Gelmon, K A, Kosma, V-M, Olson, J E, Beckmann, M W, Winqvist, R, Cross, S S, Severi, G, Huntsman, D, Pylkäs, K, Ellis, I, Nielsen, T O, Giles, G, Blomqvist, C, Fasching, P A, Couch, F J, Rakha, E, Foulkes, W D, Blows, F M, Bégin, L R, van't Veer, L J, Southey, M, Nevanlinna, H, Mannermaa, A, Cox, A, Cheang, M, Baglietto, L, Caldas, C, Garcia-Closas, M, Pharoah, P D P
Publicado em 2012

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

Por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado em 2014

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Por Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G., Biganzoli, L., Cardoso, M. J., Carey, L., Corneliussen-James, D., Curigliano, G., Dieras, V., El Saghir, N., Eniu, A., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Gennari, A., Harbeck, N., Hudis, C., Kaufman, B., Krop, I., Mayer, M., Meijer, H., Mertz, S., Ohno, S., Pagani, O., Papadopoulos, E., Peccatori, F., Penault-Llorca, F., Piccart, M. J., Pierga, J. Y., Rugo, H., Shockney, L., Sledge, G., Swain, S., Thomssen, C., Tutt, A., Vorobiof, D., Xu, B., Norton, L., Winer, E.
Publicado no Ann Oncol (2017)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Por Cardoso, F, Costa, A, Senkus, E, Aapro, M, André, F, Barrios, C H, Bergh, J, Bhattacharyya, G, Biganzoli, L, Cardoso, M J, Carey, L, Corneliussen-James, D, Curigliano, G, Dieras, V, El Saghir, N, Eniu, A, Fallowfield, L, Fenech, D, Francis, P, Gelmon, K, Gennari, A, Harbeck, N, Hudis, C, Kaufman, B, Krop, I, Mayer, M, Meijer, H, Mertz, S, Ohno, S, Pagani, O, Papadopoulos, E, Peccatori, F, Penault-Llorca, F, Piccart, M J, Pierga, J Y, Rugo, H, Shockney, L, Sledge, G, Swain, S, Thomssen, C, Tutt, A, Vorobiof, D, Xu, B, Norton, L, Winer, E
Publicado no Ann Oncol (2017)